M. Vaillancourt

发表

Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA

F. Labrie, C. Martel, D. Archer, 2015, Hormone molecular biology and clinical investigation.

Concentration range of serum sex steroids in normal postmenopausal women and those with diagnosis of vulvovaginal atrophy

F. Labrie, C. Martel, Yuyong Ke, 2017, Menopause.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

F. Labrie, C. Martel, D. Archer, 2015, Menopause.

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12weeks

F. Labrie, C. Martel, D. Archer, 2016, The Journal of Steroid Biochemistry and Molecular Biology.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

F. Labrie, C. Martel, D. Archer, 2016, Menopause.

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study

L. Derogatis, F. Labrie, C. Martel, 2016, Hormone molecular biology and clinical investigation.

Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration

F. Labrie, C. Martel, D. Archer, 2015, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner

F. Labrie, C. Martel, D. Archer, 2015, Climacteric : the journal of the International Menopause Society.

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause

F. Labrie, C. Martel, D. Archer, 2017, Menopause.

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.

L. Derogatis, F. Labrie, C. Martel, 2015, The journal of sexual medicine.

Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury.

P. Guertin, F. Prince, D. Mongeon, 2017, Current pharmaceutical design.

Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator

F. Labrie, C. Martel, D. Archer, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.

L. Derogatis, F. Labrie, C. Martel, 2015, The journal of sexual medicine.

In Reply.

F. Labrie, C. Martel, Yuyong Ke, 2018, Menopause.